Evidence map›Paper›PMID 27695490›Full record

ArticleArchives of medical science : AMS2016

Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic stroke.

Piotr Kusak, Danuta Czarnecka, Matthew Gissel, Krzysztof Plens, Saulius Butenas, Anetta Undas

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Analysis of factor XIa, factor IXa and tissue factor activity in burn patients.Burns : journal of the International Society for Burn Injuries · 2018
    Article
  6. Article
  7. Correlation between factor (F)XIa, FIXa and tissue factor and trauma severity.The journal of trauma and acute care surgery · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Piotr KusakInstitute of Cardiology, Jagiellonian University School of Medicine, Krakow, Poland.
Danuta CzarneckaInstitute of Cardiology, Jagiellonian University School of Medicine, Krakow, Poland.
Matthew GisselDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA.
Krzysztof PlensKrakow Cardiovascular Research Institute, Krakow, Poland.
Saulius ButenasDepartment of Biochemistry, University of Vermont, Burlington, Vermont, USA.
Anetta UndasInstitute of Cardiology, Jagiellonian University School of Medicine, Krakow, Poland.
Jagiellonian University · PLUniversity of Vermont · USInstitute of Cardiology · PLKrakow Cardiovascular Research Institute · PL

Funding

VENOUS THROMBOEMBOLISM: GENES, RISK, MANAGEMENTP01HL046703 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI BRUMMEL-ZIEDINS, KATHLEEN E · 1991 to 2011
$19.8M
NHLBI NIH HHS P01 HL046703
6 · The paper itself

Abstract

introductionPreviously, we have demonstrated that significant proportions of patients with various cardiovascular diseases have active tissue factor and active factor XIa in their plasma. In the current study, we evaluated active tissue factor and active factors (F)XI and FIX in plasma from patients with atrial fibrillation. MATERIAL AND

methodsIn 110 consecutive patients with permanent atrial fibrillation receiving warfarin, we determined active tissue factor, together with plasma FIXa and FXIa, using clotting assays by measuring the response to inhibitory monoclonal antibodies.

resultsSixteen (14.5%) patients had detectable active tissue factor and active FXIa, including 11 subjects with both factors, while FIXa was observed in 28 (25.7%) patients. The three positive groups did not differ from the patients without these factors with regard to demographic and clinical characteristics. Von Willebrand factor was higher in the active tissue factor-positive group (

conclusionsThese data suggest that circulating active coagulation factors, in particular TF and FXIa, can be detected despite oral anticoagulation in a significant proportion of patients with atrial fibrillation, and could represent novel markers of persistent prothrombotic alterations predisposing to ischemic stroke.

Indexed as

anticoagulationarrhythmiablood coagulationstroke

Identifiers

PMID27695490
PMCPMC5016572
OpenAlexW2327380708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.